Form 4: Edwards Lifesciences Controller Disposes Shares for Tax

Edwards Lifesciences' SVP, Corporate Controller, Andrew M. Dahl, disposed of 262 common shares for tax withholding purposes at $77.57 per share.

Summary

• Andrew M. Dahl, SVP, Corporate Controller at Edwards Lifesciences Corp (EW), reported a transaction on September 13, 2025.
• Dahl disposed of 262 shares of common stock at a price of $77.57 per share.
• This disposition was made to satisfy tax withholding obligations.
• Following this transaction, Dahl's beneficial ownership stands at 7,926.9331 shares of Edwards Lifesciences common stock.
• The filing also notes that it includes quarterly acquisition of shares under the Issuer's Employee Stock Purchase Plan, though specific details of such acquisition are not itemized in the transaction table.

Sentiment

Score: 5

Explanation: The filing reports a routine insider transaction for tax withholding, which is a neutral event for the company's operational performance or future prospects.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance.

Industry Context

This filing pertains to an individual insider stock transaction and does not provide information relevant to broader industry trends or competitive landscape.

Stakeholder Impact

• Shareholders: The disposition of 262 shares is a very minor event and has negligible impact on overall share structure or value.
• Employees: This transaction reflects standard equity compensation practices, which can be a positive for employee retention and alignment with company performance.

Key Dates

Recommendation

The filing details a routine insider transaction where an executive disposed of shares to cover tax withholding obligations. This is a common occurrence with equity compensation and does not typically signal a change in the company's fundamentals or the executive's long-term view. Therefore, it does not warrant a change in investment recommendation based solely on this filing.

Keywords

Edwards Lifesciences, EW, Form 4, Insider Transaction, Stock Disposition, Tax Withholding, Corporate Controller